End Cash: The amount of cash held by the company for the given period.
Castle Biosciences, Inc. (CSTL) had End Cash of $119.71M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$86.31M |
|
$9.59M |
|
$16.18M |
|
$70.13M |
|
$82.26M |
|
$4.05M |
|
$3.83M |
|
$7.88M |
|
$7.88M |
|
$9.59M |
|
$9.59M |
|
$9.59M |
|
$9.59M |
|
$4.05M |
|
$8.21M |
|
27.78M |
|
29.25M |
|
$0.35 |
|
$0.32 |
|
| Balance Sheet Financials | |
$360.15M |
|
$51.12M |
|
$171.08M |
|
$531.24M |
|
$49.39M |
|
$9.74M |
|
$26.01M |
|
$75.40M |
|
$455.83M |
|
$349.61M |
|
$455.83M |
|
28.48M |
|
| Cash Flow Statement Financials | |
$64.87M |
|
$-50.14M |
|
$6.14M |
|
$98.84M |
|
|
End Cash |
$119.71M |
$20.87M |
|
$50.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.29 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
81.25% |
|
4.69% |
|
4.69% |
|
-- |
|
9.14% |
|
11.11% |
|
$36.56M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
1.99 |
|
1.69 |
|
53.41 |
|
2.10% |
|
2.74% |
|
1.81% |
|
2.06% |
|
$16.00 |
|
$1.25 |
|
$2.22 |
|